Cases & Deals

sanofi-aventis enters into $900 million R&D/equity

Clients sanofi-aventis S.A.

Jones Day advised sanofi-aventis in its $400 million global biotech collaboration arrangement with and equity investment in Regeneron, with up to $475 million of additional research funding.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.